Share on StockTwits

Eli Lilly and (NYSE:LLY) SVP Susan Mahony sold 2,065 shares of the stock on the open market in a transaction dated Monday, July 28th. The shares were sold at an average price of $63.30, for a total transaction of $130,714.50. Following the completion of the sale, the senior vice president now directly owns 52,798 shares in the company, valued at approximately $3,342,113. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

A number of analysts have recently weighed in on LLY shares. Analysts at Argus raised their price target on shares of Eli Lilly and from $64.00 to $72.00 in a research note on Tuesday. They now have a “buy” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Eli Lilly and in a research note on Friday, July 25th. They now have a $68.00 price target on the stock. Finally, analysts at Jefferies Group reiterated a “hold” rating on shares of Eli Lilly and in a research note on Monday, July 14th. They now have a $65.00 price target on the stock, up previously from $60.00. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have given a buy rating to the company. Eli Lilly and presently has a consensus rating of “Hold” and a consensus target price of $62.92.

Shares of Eli Lilly and (NYSE:LLY) traded down 0.24% on Wednesday, hitting $62.62. The stock had a trading volume of 3,974,230 shares. Eli Lilly and has a 52 week low of $47.53 and a 52 week high of $65.70. The stock has a 50-day moving average of $62.11 and a 200-day moving average of $58.87. The company has a market cap of $67.405 billion and a P/E ratio of 19.93. Eli Lilly and also was the target of a significant decrease in short interest in the month of July. As of July 15th, there was short interest totalling 19,160,146 shares, a decrease of 11.4% from the June 30th total of 21,636,995 shares. Currently, 1.9% of the shares of the stock are short sold. Based on an average daily volume of 3,091,827 shares, the days-to-cover ratio is presently 6.2 days.

Eli Lilly and (NYSE:LLY) last announced its earnings results on Thursday, July 24th. The company reported $0.68 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.65 by $0.03. The company had revenue of $4.94 billion for the quarter, compared to the consensus estimate of $4.88 billion. During the same quarter last year, the company posted $1.16 earnings per share. Eli Lilly and’s revenue was down 16.8% compared to the same quarter last year. On average, analysts predict that Eli Lilly and will post $2.78 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Wednesday, September 10th. Stockholders of record on Friday, August 15th will be paid a dividend of $0.49 per share. This represents a $1.96 annualized dividend and a dividend yield of 3.13%. The ex-dividend date is Wednesday, August 13th.

Eli Lilly and Company discovers, develops, manufactures, and sells products, in one business segment, pharmaceutical products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.